The association of maternal COVID-19-infection during pregnancy on the neonatal immune profile and associations with later diagnosis of neurodevelopmental disorders.

导出 OA

翻译打印收藏纠错

作者： Danielle Hj,Kim ^[1] ; Lisa A,Croen ^[2] ; Ana-Maria,Iosif ^[3] ; Jennifer L,Ames ^[2] ; Stacey,Alexeeff ^[2] ; Yinge,Qian ^[2] ; Robert H,Yolken ^[4] ; Paul,Ashwood ^[5] ; Judy,Van de Water ^[6]

作者单位： Department of Internal Medicine, Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, CA, USA; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Palo Alto, CA, USA. ^[1] Division of Research, Kaiser Permanente Northern California, Pleasanton, CA, USA. ^[2] Department of Public Health Sciences, Division of Biostatistics, University of California, Davis, CA, USA. ^[3] Stanley Division of Developmental Neurovirology, Johns Hopkins School of Medicine, Baltimore, MD, USA. ^[4] Department of Medical Microbiology and Immunology, University of California, Davis, CA, USA; MIND Institute, University of California, Davis, CA, USA. ^[5] Department of Internal Medicine, Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, CA, USA; Department of Medical Microbiology and Immunology, University of California, Davis, CA, USA; MIND Institute, University of California, Davis, CA, USA. Electronic address: javandewater@ucdavis.edu. ^[6]

关键词 COVID-19 during pregnancy Cytokine Maternal immune activation (MIA)Neurodevelopmental disorder (NDD)Newborn immunity SARS-CoV-2